Outreach Effort Launched to Promote Imaging Research
On behalf of the American College of Radiology Imaging Network (ACRIN) senior scientific leadership, I am pleased to share with you our excitement about the merger with the Eastern Cooperative Oncology Group (ECOG) to form the ECOG-ACRIN Cancer Research Group. In particular, we look forward to working with you to expand your clinical research portfolio to include trials with imaging research aims, such as the recently activated E2410 trial (Phase II Trial of Response-adapted Therapy Based on PET for Bulky Stage I and II Classical Hodgkin Lymphoma).
We also look forward to new initiatives in screening, cancer prevention, and health outcomes through the new ECOG-ACRIN Cancer Control and Outcomes research area, which represents a true melding of the core research capabilities of ECOG and ACRIN and enables us to proceed together with a more robust program than either group could have pursued individually.
As ECOG-ACRIN develops plans for carrying out its scientific program, we are eager to learn more about imaging research interests at community-based sites. Specifically, we want to reach out directly to individuals within your clinical setting or network who may be interested in championing participation in clinical trials with imaging aims. This outreach will help us be in a position to provide the guidance and support necessary for your institution to prepare for imaging research, such as scanner qualification, image submission, and other imaging-specific research requirements.
I encourage all incoming community-based programs affiliated with ECOG to please ensure that imaging colleagues (radiologists, nuclear medicine physicians, or physicists) within your respective institutions/networks are introduced to ECOG-ACRIN and the many exciting research opportunities available through our organization. To help us in this endeavor, please complete a brief contact form. You may also forward this letter and link to imaging colleagues for their input.
Thank you for helping us get to know you and others in this vital research community.
Mitchell D. Schnall, MD, PhD
ECOG-ACRIN Cancer Research Group